Clinico-pathologic manifestations of Iranian patients with breast cancer

Pakistan Journal of Medical Sciences

Volumn 27, Issue 1, 2011, Pages 182-185

  Attarian, Hamid ^a   Pirzadeh, Asghar ^b   Rezvani, Hamid ^a   Esfahani, Fatemeh ^a   Tabarrai, Mahdi ^a   Ghadiani, Mojtaba ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Pathological stage

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; IRAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREVALENCE; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 79551531357     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Devita, Hellman and Rosenberg's cancer: Principles and practice of oncology. Lippincott Williams and Wilkins 2008:1606-9.
2. Goya M. Iranian Annual Cancer Registration Report 2003. Ministry of Health an Medical Education, Health Deputy, Center for Disease Control and Prevention. March 2005 (Persian).
3. Screening for Breast Cancer. http://www.who.int/cancer/detection/en/.
4. American Cancer Society. Cancer facts and figures 2005. Atlanta: American Cancer society, 2005: 9.
5. Tan BK, Lim GH, Czene K Hall P, Chia KS. Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast Cancer Res 2009;11(1):R4. Epub 2009 Jan 24.
6. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: Results of a multi-center study. Asian Pac J Cancer Prev 2004;5:24-7.
7. Haghighat S, Akbari ME, Holakouei K, Rahimi A, Montazeri A. Factors predicting fatigue in breast cancer patients. Support Care Cancer 2003;11:533-8.
8. Fallahazad V, Kamalian N, Gransar A. The prevalence of estrogen and progesterone receptors in Breast cancer in Shariati general hospital of Tehran 2000-2002. J Tehran Med Faculty 2004;62:745-8 (Persian).
9. Azarhoosh R, Golalipoor MJ, Behnampoor N, Basharkhah A. Grading of malignant breast tumors according to histological characteristics. Gorgan Med J 1999;4:32-8 (Persian).
10. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: A review of 903 case records. Public Health 2000;114(2):143-5.
11. Nandakumar A, Ramnath T, Roselind FS, Shobana B, Prabhu K. Two-Year Report of the Population based Cancer Registries 1999-2000. Bangalore: National Cancer Registry Programme, Indian Council of Medical Research, 2005.
12. Parkin DM, Whelan SL, Ferlay J. Teppo L, Thomas DB (eds), Cancer incidence in five continents, Vol. VIII. Author: Levi F. Ann Oncol 1999;10;3:254.
13. Ghafoor A, Jemal A, Ward E Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003;53(6):342-55.
14. Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005;23(24):5526-33.
15. Hawley ST, Hofer TP, Hawley S, Lantz PM, Janz NK, Schwartz K, et al. Correlates of between-surgeon variation in breast cancer treatments. Med Care 2006;44(7):609-16.
16. Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST. Stage 0 to stage III breast cancer in young women. J Am Coll Surg 2000;190(5):523-9.
17. Chopra R. The Indian scene. J Clini Oncol 2001;19(18):106-11.
18. Althuis MD, Fergenbaum JH, Garcia-closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor of breast cancer: A systematic review of literature. Cancer Epidemia 2004;13:1558-68.